Fujita Health University · Faculty of Medicine / Graduate School of Medicine · 講師

Research keywordshepatocellular carcinoma・chronic hepatitis B・metabolic dysfunction-associated steatohepatitis・immune checkpoint inhibitors・gut microbiota・liver injury・systemic therapy

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Efficacy of Second-line Lenvatinib for Hepatocellular Carcinoma After Early Progression on Atezolizumab-Bevacizumab.2026
• Gut microbes associated with functional cure of chronic hepatitis B.2025
• Alcoholic Hepatitis in a Japanese Hospital: Losing Contact With Some Patients After Delirium Tremens May Lead to Missed Critical Events.2025
• 【免疫治療の有害事象とその管理up-to-date 2025】免疫チェックポイント阻害薬によって生じる肝障害2025 · 腫瘍内科

• NASHに対する新規治療の開発2022
• メタボリックシンドロームに対する乳歯歯髄幹細胞培養上清を用いた新規治療の開発2021

• Official profile